Wray, Blackfoot, ID /ID# 24333 — Blackfoot, Idaho

Wray, Blackfoot, ID /ID# 24333 is a clinical research site located in Blackfoot, Idaho, United States 83221.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Wray, Blackfoot, ID /ID# 24333 has participated in 1 clinical trials.

Therapeutic areas: Chronic Plaque Psoriasis.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Blackfoot

Browse all research sites in Idaho · View every site in Blackfoot

• Bingham Memorial Hospital /ID# 205606
• Bingham Memorial Hospital /ID# 170110
• Bingham Memorial Hospital
• Bingham Memorial Hospital Site Number : 8400067
• Bingham Memorial Hospital - Blackfoot- Site Number : 8400114
• Bingham Memorial Hospital /ID# 201130
• Elite Clinical Trials
• Elite Clinical Trials LLLP
• Novo Nordisk Investigational Site
• Synergy Research Site
• GSK Investigational Site
• Grove Creek Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wray, Blackfoot, ID /ID# 24333?

Wray, Blackfoot, ID /ID# 24333 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wray, Blackfoot, ID /ID# 24333 conducted?

Wray, Blackfoot, ID /ID# 24333 has 1 clinical trials on record. Their work covers Chronic Plaque Psoriasis.

Is Wray, Blackfoot, ID /ID# 24333 accredited by Crixeo Clinical Trials?

Wray, Blackfoot, ID /ID# 24333 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Wray, Blackfoot, ID /ID# 24333?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.